Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1548913

Mac-1 Blockade Impedes Adhesion-Dependent Neutrophil Extracellular Trap Formation and Ameliorates Lung Injury in LPS-induced Sepsis

Provisionally accepted
Jinhua Fang Jinhua Fang 1Hongguang Ding Hongguang Ding 1Jiaqi Huang Jiaqi Huang 2Wang Liu Wang Liu 2Tiantian Hong Tiantian Hong 2Junxian Yang Junxian Yang 1Zhiwei Wu Zhiwei Wu 1Zhuo Li Zhuo Li 1Shiying Zhang Shiying Zhang 1Peimin Liu Peimin Liu 1Ying Fang Ying Fang 2Jianhua Wu Jianhua Wu 2Xin Li Xin Li 1Jiangguo Lin Jiangguo Lin 1*
  • 1 Guangdong Provincial People's Hospital, Guangzhou, China
  • 2 South China University of Technology, Guangzhou, China

The final, formatted version of the article will be published soon.

    Sepsis is a common critical condition that can lead to multiple organ injury. Sepsis-induced acute respiratory distress syndrome (ARDS) is frequently an important cause of poor prognosis and is associated with high mortality rates, despite existing therapeutic interventions. Neutrophil infiltration and extracellular traps (NET) are implicated in acute lung injury (ALI) and ARDS following sepsis. As circulating neutrophils infiltrate infected tissues, they come into direct contact with vascular endothelial cells (ECs). Although the ability of NETs to induce endothelial damage is well established, the specific role of direct EC-neutrophil interactions in NET formation and lung injury during sepsis is not fully understood. In this study, NET formation was assessed when neutrophils were co-culture with ECs or separated from them and stimulated with phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS), lipoteichoic acid (LTA), or septic plasma. We found that adhesion of neutrophils on ECs is critical in NET formation in response to LPS, LTA, or septic plasma in vitro. Blocking the macrophage-1 antigen (Mac-1) impeded NET formation, while inhibiting P-selectin glycoprotein ligand-1 (PSGL-1) or leukocyte function-associated antigen-1 (LFA-1) did not. This adhesion-dependent NET formation was reliant on the influx of extracellular calcium and peptidylarginine deiminase 4 (PAD4)-mediated citrullination of histone H3. However, Mac-1 blockade did not alter calcium influx. In a murine model of LPS-induced sepsis, Mac-1 blockade reduced NET release, lowered inflammatory cytokine levels, mitigated endothelial damage, and attenuated lung injury. Our findings offer insights into the critical role of EC-neutrophil direct contact in NET formation during sepsis and propose Mac-1 as a potential therapeutic target.

    Keywords: Sepsis, neutrophil extracellular traps, integrin Mac-1, Endothelial Cells, Peptidylarginine deiminase 4

    Received: 20 Dec 2024; Accepted: 07 Mar 2025.

    Copyright: © 2025 Fang, Ding, Huang, Liu, Hong, Yang, Wu, Li, Zhang, Liu, Fang, Wu, Li and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jiangguo Lin, Guangdong Provincial People's Hospital, Guangzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more